Developmental Studies of Brca1 and Brca2 Knock-Out Mice

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 4, 1998, Pages 431-445

  Hakem, Razqallah ^a   De La Pompa, José Luis ^a   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brca1; Brca2; Cancer; Gastrulation; Proliferation; Trophoblast

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ANIMAL; BREAST TUMOR; FEMALE; FETUS DEATH; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUSE; MOUSE MUTANT; OVARY TUMOR; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETAL DEATH; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, BRCA1; GENES, P53; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0032173693     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018792200700     Document Type: Article

References (47)

1. E. R. Fearon (1997). Human cancer syndromes: clues to the origin and nature of cancer. Science 278:1043-1050.
2. Y. Miki, J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, and et al (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
3. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, and G. Micklem (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
4. S. V. Tavtigian, J. Simard, J. Rommens, F. Couch, D. Shattuck-Eidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. Stoppa-Lyonnet, C. Belanger, R. Bell, S. Berry, R. Bogden, Q. Chen, T. Davis, M. Dumont, C. Frye, T. Hattier, S. Jammulapati, T. Janecki, P. Jiang, R. Kehrer, J. F. Leblanc, D. E. Goldgar, and et al (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:333-337.
5. D. Bertwistle, and A. Ashworth (1998). Functions of BRCA1 and BRCA2 genes. Curr. Opin. Genet. Dev. 8:14-20.
6. H. Zhang, G. Tombline, and B. L. Weber (1998). BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion? Cell. 92:433-436.
7. D. Ford, D. F. Easton, M. Stratton, S. Narod, D. Goldgar, P. Devilee, D. T. Bishop, B. Weber, G. Lenoir, C. J. Chang, H. Sobol, M. D. Teare, J. Struewing, A. Arason, S. Scherneck, J. Peto, T. R. Rebbeck, P. Tonin, S. Neuhausen, R. Barkardottir, J. Eyfjord, H. Lynch, B. A. Ponder, S. A. Gayther, J. M. Birch, A. Lindblom, L. D. Stoppa, Y. Bignon, A. Borg, U. Hamann, N. Haites, R. J. Scott, C. M. Maugard, H. Vasen, S. Seitz, A. L. Cannon, A. Schofield, H. M. Zelada, Breast, Cancer, Linkage, and Consortium (1998). Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families. Am. J. Hum. Genet. 62:676-789.
8. S. D. Merajver, T. M. Pham, R. F. Caduff, M. Chen, E. L. Poy, K. A. Cooney, B. L. Weber, F. S. Collins, C. Johnston, and T. S. Frank (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet. 9:439-443.
9. K. A. Foster, P. Harrington, J. Kerr, P. Russell, R. A. DiCioccio, I. V. Scott, I. Jacobs, G. Chenevix-Trench, B. A. Ponder, and S. A. Gayther (1996). Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res. 56:3622-3625.
10. L. C. Wu, Z. W. Wang, J. T. Tsan, M. A. Spillman, A. Phung, X. L. Xu, M. C. Yang, L. Y. Hwang, A. M. Bowcock, and R. Baer (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14:430-440.
11. T. H. Thai, F. Du, J. T. Tsan, Y. Jin, A. Phung, M. A. Spillman, H. F. Massa, C. Y. Muller, R. Ashfaq, J. M. Mathis, D.S. Miller, B. J. Trask, R. Baer and A. M. Bowcock (1998). Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum. Mol. Genet. 7:195-202.
12. T. Ouchi, A. Monteiro, A. August, S. A. Aaronson and H. Hanafusa (1998). BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. U.S.A. 95:2302-2306.
13. R. Scully, S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston and J. D. Parvin (1997). BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. U.S.A. 94:5605-5610.
14. J. Milner, B. Ponder, D. L. Hughes, M. Seltmann and T. Kouzarides (1997). Transcriptional activation functions in BRCA2. Nature 386:772-773.
15. S. K. Sharan, M. Morimatsu, U. Albrecht, D. S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty and A. Bradley (1997). Embryonic lethality and radiation hyper sensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386:804-810.
16. R. Mizuta, J. M. LaSalle, H. L. Cheng, A. Shinohara, H. Ogawa, N. Copeland, N. A. Jenkins, M. Lalande, and F. W. Alt (1997). RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. U.S.A. 94:6927-6932.
17. A. Shinohara, H. Ogawa, Y. Matsuda, N. Ushio, K. Ikeo, and T. Ogawa (1993). Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat. Genet. 4:239-243.
18. R. Scully, J. Chen, R. L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and D. M. Livingston (1997). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425-435.
19. R. Scully, J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D. M. Livingston (1997). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275.
20. T. F. Lane, C. Deng, A. Elson, M. S. Lyu, C. A. Kozak, and P. Leder. (1995). Expression of Brcal is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Der. 9:2712-2722.
21. S. K. Sharan, and A. Bradley (1997). Murine Brca2: sequence, map position, and expression pattern. Genomics 40:234-241.
22. F. Connor, A. Smith, R. Wooster, M. Stratton, A. Dixon, E. Campbell, T. M. Tait, T. Freeman, and A. Ashworth (1997). Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum. Mol. Genet. 6:291-300.
23. S. T. Marquis, J. V. Rajan, A. Wynshaw-Boris, J. Xu, G. Y. Yin, K. J. Abel, B. L. Weber, and L. A. Chodosh (1995). The developmental pattern of Brcal expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11:17-26.
24. J. V. Rajan, S. T. Marquis, H. P. Gardner, and L. A. Chodosh (1997). Developmental expression of Brca2 colocalizes with Brcal and is associated with proliferation and differentiation in multiple tissues. Dev. Biol. 184:385-401.
25. P. E. Blackshear, S. M. Goldsworthy, J. F. Foley, K. A. McAllister, L. M. Bennett, N. K. Collins, D. O. Bunch, P. Brown, R. W. Wiseman, and B. J. Davis (1998). Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene 16:61-68.
26. J. A. Kreidberg, H. Sariola, J. M. Loring, M. Maeda, J. Pelletier, D. Houseman, and R. Jaenisch (1993). WT-1 is required for each kidney development. Cell 74:679-691.
27. T. Matsuyama, T. Kimura; M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, J. Potter, C. L. Furlonger, A. Narandran, H. Suzuki, P. Ohashi, C. J. Paige, T. Taniguchi, and T. W. Mak (1993). Targeted disruption of IRF-1 or IRF-2 results in abnormal type 1 IFN gene induction and aberrant lymphocyte development. Cell 75:83-97.
28. T. Jacks (1996). Tumor Suppressor gene mutations in mice. Annu. Rev. Genet. 30:603-636.
29. B. O. Williams and T. Jacks. (1996) Mechanisms of carcinogenesis and the mutant mouse. Current opinion in Benet. and Dev. 6:65-70.
30. L. C. Gowen, B. L. Johnson, A. M. Latour, K. K. Sulik, and B. H. Koller (1996). Brcal deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:191-194.
31. R. Hakem, J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009-1023.
32. C. Y Liu, A. Flesken-Nikitin, S. Li, Y. Zeng, and W. H. Lee (1996). Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1835-1843.
33. T. Ludwig, D. L. Chapman, V. E. Papaioannou, and A. Efstratiadis (1997). Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1226-1241.
34. A. Suzuki, J. L. de la Pompa, R. Hakem, A. Elia, R. Yoshida, R. Mo, H. Nishina, T. Chuang, A. Wakeham, A. Itie, W. Koo, P. Billia, A. Ho, M. Fukumoto, C. C. Hui and T. W. Mak (1997). Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1242-1252.
35. F. Connor, D. Bertwistle, P. J. Mee, G. M. Ross, S. Swift, E. Grigorieva, V. L. Tybulewicz, and A. Ashworth (1997). Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17:423-430.
36. L. S. Friedman, F. C. Thistlethwaite, K. J. Patel, V. P. C. C. Yu, H. Lee, and A. R. Venkitaraman, K. J. Abel, M. B. L. Carlton, S. M. Hunter, W. H. Colledge, M. J. Evans, and A. J. Ponder (1998). Thymic Lymphomas in Mice with a truncating Mutation in Brca2. Cancer Res. 58:1338-1343.
37. K. J. Patel, V. P. C. C. Yu, H. Lee, A. Corcran, F. C. Thistlethwaite, M. J. Evans, W. H. Colledge, L. S. Friedman, B. A. J. Ponder, and A. R. Venkitaraman (1998). Involvement of Brca2 in DNA repair. Mol. Cell. 1:347-357.
38. F. Guillemot, A. Nagy, A. Auerbach, J. Rossant and A. L. Joyner (1994). Essential role of Mash-2 in extraembryonic development. Nature 371:333-336.
39. C. A. Wilson, M. N. Payton, G. S. Elliott, F. W. Buaas, E. E. Cajulis, D. Grosshans, L. Ramos, D. M. Reese, D. J. Slamon and F. J. Calzone. (1997). Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-deltal 1b. Oncogene 14:1-16.
40. R. Montes de Oca Luna, D. S. Wagner, and G. Lozano (1995). Rescue of early embryonic lethality in MDM2-deficient mice by deletion of p53. Nature 378:203-206.
41. S. N. Jones, A. E. Roe, L. A. Donehower, and A. Bradley (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206-208.
42. R. Hakem, J. L. de la Pompa, A. Elia, J. Potter and T. W. Mak (1997). Partial rescue of Brcal (5-6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16:298-302.
43. J. Brugarolas, and T. Jacks (1997). Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brcal and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair. Nat. Med. 3:721-722.
44. T. Crook, S. Grossland, M. R. Crompton, P. Osin, and B. A. Gusterson (1997). p53 mutations in BRCA1-associated familial breast cancer. Lancet 350:638-639.
45. S. Gretarsdottir, S. Thorlacius, R. Valgardsdottir, S. Gudlaugsdottir, S. Sigurdsson, M. Steinarsdottir, J. G. Jonasson, J. K. Anamthawat and J. E. Eyfjord (1998). BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res. 58:859-862.
46. D. S. Lim, and P. Hasty (1996). A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol. 16:7133-7143.
47. H. Shibata, K. Toyama, H. Shioya, M. Ito, M. Hirota, S. Hasegawa, H. Matsumoto, H. Takano, T. Akiyama, K. Toyoshima, R. Kanamaru, Y. Kanegae, I. Saito, Y. Nakamura, K. Shiba and T. Noda (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the Ape gene. Science 278:120-123.